4.7 Article

Prospective Multicenter International Surveillance of Azole Resistance in Aspergillus fumigatus

期刊

EMERGING INFECTIOUS DISEASES
卷 21, 期 6, 页码 1041-1044

出版社

CENTERS DISEASE CONTROL & PREVENTION
DOI: 10.3201/eid2106.140717

关键词

-

资金

  1. Investigator Initiated Studies Program (IISP) of Merck, Sharp Dohme (MSD)
  2. Gilead
  3. MSD
  4. Astellas
  5. Pfizer
  6. Bio-Rad
  7. Ferrer International
  8. Schering
  9. Innothera

向作者/读者索取更多资源

To investigate azole resistance in clinical Aspergillus isolates, we conducted prospective multicenter international surveillance. A total of 3,788 Aspergillus isolates were screened in 22 centers from 19 countries. Azole-resistant A. fumigatus was more frequently found (3.2% prevalence) than previously acknowledged, causing resistant invasive and noninvasive aspergillosis and severely compromising clinical use of azoles.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据